Research progress in the treatment of retinitis pigmentosa
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

Innovation Platform Open Fund Project of Hunan Provincial Department of Education(No.16K065); Hunan University of Chinese Medicine National Key Discipline Open Fund Priority Grant Project(No.2015ZYZD02); Hunan Provincial Key Laboratory Project for Preventing and Treating Ophthalmology and Otorhinolaryngology(No.2017TP1018); Science and Technology Plan Project of Changsha City(No.kc1704005); Key Subject Construction Project for Traditional Chinese Medicine Ophthalmology by the State Administration of Traditional Chinese Medicine; Construction Project of Key Discipline of Traditional Chinese Medicine in Hunan Province

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Retinitis Pigmentosa(RP)is a group of inherited retinal diseases characterized by progressive photoreceptor cells loss and pigment epithelial cell dysfunction. It is one of the most common disease worldwide which leads to blindness, and there were no effective treatments for RP in the past decades. Recently, lots of methods were considered effective to treat with RP, including stem cell therapy, gene therapy, neuroprotective therapy, nutritional therapy, hyperbaric oxygen therapy, retinal transplantation and traditional Chinese medicine. In this review, we conducted a comprehensive analysis and assessment on the findings of the progress of RP treatment at domestic and overseas.

    Reference
    Related
    Cited by
Get Citation

Chen Ou, Ying Wang, Jian Xu, et al. Research progress in the treatment of retinitis pigmentosa. Guoji Yanke Zazhi( Int Eye Sci) 2018;18(9):1608-1611

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:May 10,2018
  • Revised:July 24,2018
  • Adopted:
  • Online: August 17,2018
  • Published: